Dachaigh › Gnìomhan › Regulatory Affairs Managers › Waltham, MA
Regulatory Affairs Managers ann an Waltham, MA: Tuarastalan H-1B
25 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an Waltham, MA. Tuarastal bunasach meadhanach $202,000; leth meadhanach $155,000–$235,342.
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $141,064 |
| Ìre II (càileachail) | $171,000 |
| Ìre III (eòlach) | $177,500 |
| Ìre IV (gu lèir comasach) | $262,500 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| Alkermes, Inc. | 4 | $178,500 |
| McKinsey & Company, Inc. United States | 2 | $360,000 |
| Deciphera Pharmaceuticals, LLC | 2 | $146,742 |
| Apellis Pharmaceuticals Inc. | 2 | $140,000 |
| AstraZeneca Pharmaceuticals LP | 2 | $232,842 |
| Aerovate Therapeutics, Inc. | 1 | $225,000 |
| DynamiCure Biotechnology LLC | 1 | $260,000 |
| Seres Therapeutics, Inc. | 1 | $173,000 |
| Cornerstone Medical (USA) Inc. | 1 | $155,000 |
| Dyne Therapeutics, Inc. | 1 | $265,000 |
| Q32 Bio Inc. | 1 | $182,000 |
| Cogent Biosciences, Inc. | 1 | — |
| Apogee Therapeutics, Inc. | 1 | — |
| Zenas BioPharma (USA) LLC | 1 | $295,000 |
| BostonGene Corporation | 1 | $230,000 |
| Mercy BioAnalytics, Inc. | 1 | $130,127 |
| Miltenyi Biomedicine, Inc. | 1 | $171,000 |
| TScan Therapeutics, Inc. | 1 | $225,000 |
Tiotalan dreuchd
- Director of Geographic Compliance2
- Regulatory Affairs Manager, Device2
- Associate Director, Regulatory Affairs2
- Director, Regulatory Affairs1
- Vice President, Global IP Strategy1
- Director/PV Scientist1
- Manager, Regulatory CMC1
- Regulatory Affairs Manager1
- Senior Manager, Regulatory Affairs CMC1
- Senior Director, Regulatory Information Management1
- Regulatory Affairs Director “ Oncology1
- Director, Pharmacovigilance Scientist1
- Executive Director, Regulatory Affairs CMC and Device Regula1
- Executive Director, Regulatory Affairs1
- Head of Quality Assurance and Regulatory Affairs1
Luchd-taic H-1B ann an Waltham, MA →
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).